Germaine Hanquet

Summary

Country: Belgium

Publications

  1. ncbi Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 28:3920-8. 2010
  2. ncbi Pneumococcal serotypes in children in 4 European countries
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Emerg Infect Dis 16:1428-39. 2010
  3. ncbi Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 29:2856-64. 2011
  4. ncbi Impact of rotavirus vaccination on laboratory confirmed cases in Belgium
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 29:4698-703. 2011
  5. ncbi Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)
    Germaine Hanquet
    Health Care Knowledge Centre, Brussels, Belgium
    Vaccine 29:370-7. 2011

Detail Information

Publications5

  1. ncbi Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 28:3920-8. 2010
    ..PCV impact was monitored in 11/15 countries using it. We propose steps for the monitoring of incidence rates and serotype distribution at EU level, to assess the need to introduce PCV and monitor its impact once introduced...
  2. ncbi Pneumococcal serotypes in children in 4 European countries
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Emerg Infect Dis 16:1428-39. 2010
    ..New vaccines targeting these serotypes are available, but serotype dynamics needs further exploration that accounts for underreporting and prevaccine trends...
  3. ncbi Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 29:2856-64. 2011
    ..Estimation of PCV7 impact comparing pre- and post-vaccination data should adjust for pre-vaccine trends, and serotype dynamics need further exploration...
  4. ncbi Impact of rotavirus vaccination on laboratory confirmed cases in Belgium
    Germaine Hanquet
    Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 29:4698-703. 2011
    ..7-81.4%). The rotavirus season was delayed compared to pre-vaccination seasons. Laboratory data provide a crude estimation of vaccination impact, but analysis of in-patient data will be needed to assess the impact on severe disease...
  5. ncbi Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)
    Germaine Hanquet
    Health Care Knowledge Centre, Brussels, Belgium
    Vaccine 29:370-7. 2011
    ..Preparedness for future pandemics could involve improved decision-making on target groups and increased communication on vaccine safety...